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Serotonylation of Small GTPases Is a Signal
Transduction Pathway that Triggers
Platelet -Granule Release
action with von Willebrand factor (vWf), which forms a
bridge between collagen within the damaged vessel wall
and the platelet receptor glycoprotein GPIb. At in vivo
rheological situations where platelets are flowing with
high speed in the bloodstream, the only reaction that
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can initiate thrombogenesis is the interaction of vWf1Max-Planck-Institute for Molecular Genetics
with GPIb. This reversible adhesion allows platelets toIhnestrasse 73
roll over the damaged area, which is then followed byD-14195 Berlin
a firm adhesion mediated by the collagen receptorsGermany
21 and GPVI. Therefore, the importance of vWf in2 Institute for Anatomy
promoting both primary adhesion and aggregation un-Humboldt University Berlin
der high-shear conditions is now well established. How-Charite´
ever, the efficiency with which platelets adhere and ag-Philippstrasse 12
gregate at sites of vessel wall injury is dependent onD-10117 Berlin
the synergistic action of various adhesive and solubleGermany
agonist receptors, and the contribution especially of the3 Max Delbru¨ck Center for Molecular Medicine
soluble agonists remains obscure.(MDC)
Serotonin (5-hydroxytryptamine; 5-HT), was first iso-Robert-Ro¨ssle-Strasse 10
lated fifty-five years ago and identified to be the vaso-D-13092 Berlin-Buch
constrictor compound contained in serum (Rapport etGermany
al., 1948). While its pressor effect has been investigated
in great detail (Cohen et al., 1983), only little attention
has been paid to the aggregation response of bloodSummary
platelets upon 5-HT stimulation. In contrast to adeno-
sine diphosphate (ADP), 5-HT is considered only as aSerotonin is a neurotransmitter in the central nervous
weak agonist although ADP and 5-HT are both highlysystem. In the periphery, serotonin functions as a ubiq-
concentrated in platelet dense bodies together withuitous hormone involved in vasoconstriction and platelet
adenosine triphosphate (ATP) and Ca2 cations (653function. Serotonin is synthesized independently in
mM, 65 mM, 436 mM, and 2.2 M, respectively; McNicolperipheral tissues and neurons by two different rate-
and Israels, 1999). The interest in further studies intolimiting tryptophan hydroxylase (TPH) isoenzymes.
the role of 5-HT has recently even been diminished byHere, we show that mice selectively deficient in pe-
the G protein hypothesis which postulates that plateletripheral TPH and serotonin exhibit impaired hemosta-
aggregation requires the concomitant activation of atsis, resulting in a reduced risk of thrombosis and
least one Gi- and one Gq-coupled receptor (Maayani etthromboembolism, although the ultrastructure of the
al., 2001a). The 5-HT2A receptor (5-HT2AR) has beenplatelets is not affected. While the aggregation of sero-
shown to be the only serotonergic receptor on the plate-tonin-deficient platelets in vitro is apparently normal,
let membrane (Killam and Cohen, 1991) mediating Gq-their adhesion in vivo is reduced due to a blunted
dependent intracellular Ca2 mobilization and proteinsecretion of adhesive -granular proteins. In elucidating
kinase C (PKC) activation (Offermanns et al., 1997). How-the mechanism further, we demonstrate that serotonin is
ever, characterization of the 5-HT action has been elu-transamidated to small GTPases by transglutaminases
sive, and moreover, deaggregation is an integral compo-
during activation and aggregation of platelets, rendering
nent of the platelet response to ADP (Maayani et al.,
these GTPases constitutively active. Our data provides 2001b) suggesting a degree of complexity to the overall
evidence for a receptor-independent signaling mecha- response that is not explained by our current knowledge
nism, termed herein as “serotonylation,” which leads of platelet physiology.
to -granule exocytosis from platelets. In addition to the 5-HT2AR, the plasma membrane
5-HT reuptake transporter (SERT) has been found highly
Introduction expressed in platelets (Lesch et al., 1993). Serotonin
specific reuptake inhibitors (SSRI), such as fluoxetine
Cardiovascular and cerebrovascular diseases are the (Flx) attenuate aggregation and dense and -granule
leading causes of mortality throughout the world. Blood secretion by a yet to be identified mechanism (Serebru-
platelets play a central role not only in hemostasis but any et al., 2001). In contrast, another reuptake blocker,
also in the pathogenesis of thrombosis and atheroscle- ()-fenfluramine (Fen) has been proven to have little
rosis, with platelet adhesion to a damaged blood vessel inhibitory effects on ADP- or collagen-induced shape
being the initial trigger for the formation of either an change and aggregation and elicits no aggregation by
effective hemostatic plug or an intravascular thrombus itself (Buczko et al., 1975; Barradas et al., 1983). It is
(Denis et al., 1998; Ni et al., 2000; Jackson et al., 2003). common knowledge, that Flx acts directly and specifi-
Platelets adhere to the subendothelium through an inter- cally on SERT while Fen after being transported into the
cytoplasm by SERT also acts on the vesicular mono-
amine transporter 2 (VMAT2) and reverses the transport*Correspondence: dwalther@molgen.mpg.de
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by VMAT2 as well as by SERT thereby releasing 5-HT platelet aggregation, especially in mediating exocytosis
by a nonexocytotic mechanism. Explanations for these and cytoskeleton rearrangement (Shirakawa et al., 2000;
pharmacological findings are further complicated by the Azim et al., 2000; Schoenwaelder et al., 2002). Therefore,
fact that 5-HT2AR antagonists alone attenuate aggrega- it was tempting to speculate that 5-HT might be rapidly
tion and platelet-vessel wall interactions (De Clerk et transamidated to small GTPases during platelet activa-
al., 1984) by an unknown mechanism. tion and aggregation, immediately leading to a substan-
As mentioned above, vWf is an essential player in tial increase of constitutively active signaling pathways.
the platelet-vessel wall interaction (Denis et al., 1998). Recently, we have generated mice deficient for the
Vascular endothelial cells (ECs) synthesize and release rate-limiting enzyme in the 5-HT biosynthesis, trypto-
vWf either constitutively or by a regulated pathway trig- phan hydroxylase (TPH), to elucidate the multitude of
gered by an unknown mechanism from Weibel-Palade physiological effects of this monoamine in primary he-
bodies at the place of vascular injury. As reported by mostasis, immune responses, neurophysiology, and
Palmer et al. (1994) and confirmed later (Schlu¨ter and embryology (Walther and Bader, 1999; Walther et al.,
Bohnensack, 1999), 5-HT enhances vWf secretion from 2003). We discovered a second TPH isoform specifically
ECs in vitro, raising the question, whether 5-HT could expressed in neurons, and have named this second iso-
be an effector for vWf secretion, not only from ECs, but form TPH2 and the previously known isoform TPH1 (Wal-
also from platelets, in primary hemostasis. ther et al., 2003). Tph1/ mice contain normal levels of
Although platelets only contain 20% of the vWf pres- 5-HT in the brain, but are depleted of the monoamine
ent in the circulation, they store multimeric forms of vWf in peripheral tissues and fluids (Walther et al., 2003),
that are much larger than those found in plasma (Siess, rendering these animals an excellent model for studies
1989). In ECs, the same larger multimeric forms are on the controversially discussed multiple effects of 5-HT
stored in Weibel-Palade bodies. Interestingly, patients outside the central nervous system, especially in pri-
with von Willebrand disease type IIA who only lack the mary hemostasis.
larger multimeric forms but apart from that have normal Here, we show that -granule secretion depends on
vWf concentrations in the circulation show a prolonged high cytoplasmic 5-HT and Ca2 concentrations and that
bleeding time (Siess, 1989), indicating that the larger 5-HT is then transamidated to small GTPases rendering
multimeric forms of vWf, stored in platelets and ECs, these GTPases constitutively active. Thus, we have
are predominantly active in primary hemostasis, espe- identified a receptor-independent intracellular signaling
cially at high-shear stress rates (Schoenwaelder et al., pathway for 5-HT.
2002). Platelet -granules are exocytosed only a few
seconds after platelet stimulation whereas Weibel- Results
Palade body release from ECs takes up to 30 min
(Palmer et al., 1994). Therefore, platelet-derived, highly Bleeding Time Prolongation and Platelet
multimeric vWf must be considered to be of higher im- Function in Tph1/ Mice
portance in primary hemostasis than vWf from ECs. Survival is identical in Tph1/ and wild-type mice, and
It has recently been shown that the platelet transglu-
blood platelet counts do not differ between wild-type mice
taminase (TG) FXIIIa uses 5-HT as a substrate to transam-
(730,000  70,000/l; n  5) and TPH1-deficient mice
idate vWf and other proaggregatory proteins stored in
(790,000  200,000; n  5). The platelets of Tph1/
-granules in dually collagen and thrombin activated
mice contain only minute amounts of 5-HT (Walther etplatelets (Dale et al., 2002) thereby enhancing the adhe-
al., 2003; Ho¨ltje et al., 2003). Their morphology is normalsive properties of these proteins (Szasz and Dale, 2002).
as evaluated by electron microscopy, and they are ableMoreover, tissue TG has also been detected in platelets
to take up 5-HT by SERT and to pack it into dense(Puszkin and Raghumaran, 1985). TGs constitute a su-
granules by VMAT2 by a Gq-modulated mechanismperfamily of enzymes that catalyze the Ca2-dependent
(Ho¨ltje et al., 2003). Therefore, we could detect no stor-crosslinking of proteins via the -carboximide group
age pool deficiency (SPD) in Tph1/ mice. However, theof glutamine residues and the 	-amino group of lysine
consequence of platelets lacking only 5-HT is a majorresidues but are also able to covalently link simple pri-
bleeding diathesis leading to a four times prolongedmary amines, such as 5-HT, to glutamine residues (Dale
bleeding time of experimentally severed tail tips, aset al., 2002). TGs are not only implicated in the crosslink-
compared to control animals (Figure 1A). This phenotypeing of fibrin and extracellular matrix proteins (Greenberg
was completely reversed by application of 5-HT 15 minet al., 1991; Citron et al., 2000), but also in synapse
prior to severing the tail tips (Figure 1B). Conversely, astabilization (Citron et al., 2000) and apoptosis (Melino
similar phenotype and its rescue have been describedet al., 1994). Moreover, Bordetella dermonecrotic toxin
for beige mice, which are a model for the mostly lethal(DNT) has been identified as a TG and E. coli cytotoxic
human Chediak-Higashi syndrome (CHS) defined by anecrotizing factors (CNF) as deamidases that transami-
prominent SPD (Holland, 1976).date and deamidate the small GTPase RhoA (at Gln63),
Beige mice platelets lacking 5-HT exhibit reduced ag-and Rac1 and Cdc42 (at Gln61) (Schmidt et al., 1997,
gregability, suggesting that reduced platelet aggregabil-1999; Aktories et al., 2000; Doye et al., 2002; Masuda
ity could be one reason for the impaired primary hemo-et al., 2000). As a consequence the intrinsic GTP-
stasis also in Tph1/ mice. But surprisingly, Tph1/hydrolyzing activity is blocked rendering these small
platelets exhibited normal aggregation responses toGTPases constitutively active for their respective signal-
collagen, thrombin, and the thromboxane A2 mimeticing pathways.
U46619 in vitro (Figure 1C). Our data and the bleedingInterestingly, RhoA, Rac1, Cdc42, Rab4, and other
small GTPases are directly involved in signaling during time reversal by 5-HT application alone in the CHS model
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Figure 1. Impaired Primary Hemostasis in Tph1/ Mice
(A) Prolonged bleeding time of Tph1/ mice.
(B) Phenotype rescue by intracardial 5-HT-application. The indicated 5-HT amounts correspond to 1/10 and 10 times the normal blood
concentration after application. ***, p 
 1  105 (n  4–8).
(C) Representative platelet aggregation plots in Tyrode-HEPES buffer with the thromboxane A2 mimetic U46619 (0.5 M), thrombin (1 u/ml),
and collagen (20g/ml) as proaggregatory substances. Tph1/ and Tph1/ platelets aggregate to the same extent under the investigated con-
ditions.
(Holland, 1976) suggest a not yet characterized central in vitro using washed wild-type platelets. 5-HT alone
induced a 20% release of -granular vWf contents androle of 5-HT in the primary hemostasis process. How-
ever, an odd of in vitro aggregation studies is that irre- a collagen release of 45%, as detected in the superna-
tants of aggregated platelets by a vWf ELISA (Figure 2B).versible and reversible aggregation (agglutination) is
hardly distinguishable. In vivo, irreversible aggregation Although ADP potentiated the 5-HT-induced release, no
significant concentrations of vWf could be detected inrather than agglutination leads to mortal thromboembo-
lism and to vessel occlusion in thrombosis. Prompted by the supernatants of platelets, induced with ADP alone.
these contradictory data, we hypothesized that Tph1/
platelets might have reduced adhesive properties.
Low 5-HT Protects against Thrombosis
and Thromboembolism5-HT-Induced Release of -granular
Tph1/ animals are protected against thrombosis in avWf from Platelets
well-established in vivo model. FeCl3 induces vascularSince vWf is a major factor in irreversible platelet aggre-
injury and thrombus formation by removal of the endo-gation and adhesion, we hypothesized that 5-HT nor-
thelium and exposure of the subendothelial matrix (Nimally triggers its release, resulting in a blunted secretion
et al., 2000). In wild-type animals, two minutes afterof vWf from -granules of Tph1/ platelets lacking
FeCl3-application, numerous fluorescence-labeled, ad-5-HT. In plasma, steady-state levels of vWf and of blood
herent platelets were visible in the injured areas by usingcoagulation factor FVIII, which is bound and stabilized
intravital microscopy (Figure 3A). Moreover, formationby vWf, were not significantly different between Tph1/
and growth of thrombi proceeded all over the recordedmice and their wild-type littermates (vWf: Tph1/: 100
time culminating in vessel occlusion. However, in the11%, Tph1/: 89  30%; n  6; FVIII: Tph1/: 100 
Tph1/ mice, platelet interactions with the vessel wall20%, Tph1/: 86  29%; n  6). Thus, at least the
were unstable and thrombi in these mice failed to resistsynthesis and constitutive secretion of vWf is unaffected
high shear stress and eventually detached from the sub-in Tph1/ animals.
endothelial matrix (Figure 3A).A significant reduction of about two thirds of the
When thromboembolism is induced by the injectionpathologically prolonged bleeding time was obtained
of collagen and epinephrine the survival rate of Tph1/by infusion of vWf, which was without effect in wild-
mice is increased and the survival time of the animalstype mice (Figure 2A). Since a direct in situ measurement
which died, prolonged (Figure 3B), also indicating re-of the rapid processes at the site of vascular injury is
technically not possible, we confirmed our hypothesis duced stability of formed thrombi, in accordance to our
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Figure 2. Rescue of the Bleeding Phenotype with vWf Infusion and vWf Secretion in Vitro
(A) Partial phenotype rescue by intracardial vWf-application in the indicated doses. The effect is specific for the Tph1/ mice. *, p 
 0.05;
**, p 
 0.01 (n  4–8).
(B) Secretion of -granular contents from aggregating wild-type platelets in vitro using vWf as a marker. Collagen-induced (30 g/ml) vWf
release is more effective than the induction with the downstream mediators. Vehicle and ADP (14 M) alone do not induce the release of
-granular contents, but a significant 5-HT-induced (12 M) release can be detected. The 5-HT-induced vWf secretion is potentiated if ADP
is added together with 5-HT (14 M and 12 M, respectively). *, p 
 0.01 (n  3).
proposal that 5-HT is the crucial effector of the regulated immediately aggregate upon stimulation with the 5-HT2AR
agonist -methyl-serotonin (-ms; Figures 4E and 4F)secretion of vWf in primary hemostasis in vivo.
at concentrations that elicit no response (180 nM) or
only a weak, reversible aggregation on untreated plate-Cytoplasmic 5-HT and Ca2 Are a Prerequisite
for Platelet Aggregation lets (1.8 M; Figure 4G). The dependency on cytosolic
[5-HT]i can be appreciated by the delayed aggregationCollagen stimulation induces a pronounced shape
change and culminates in aggregation in both wild-type of Tph1/ platelets compared with wild-type platelets
(Figures 4E-4H) and the delay of Fen-treated versusand Tph1/ platelets (Figures 1C and 4A). An initial
dense body secretion, liberating 5-HT, ADP, and Ca2, Fen Flx-treated Tph1/ platelets (Figures 4E and 4F).
Since 5-HT2AR stimulation leads to Ca2 mobilizationdrives this reaction, which in turn induces -granule
release (Siess, 1989; Shirakawa et al., 2000). The syner- (Offermanns et al., 1997), high cytoplasmic [5-HT]i and
[Ca2]i must be considered a prerequisite for platelet ag-gistic action of ADP, Ca2, and 5-HT may explain the
preserved aggregation of Tph1/ platelets in vitro, gregation.
Moreover, we found that under our experimental con-given that they contain about 5% of wild-type 5-HT
amounts (Ho¨ltje et al., 2003), which appears to be still ditions about 40% of preloaded 14C-5-HT remain in a
nonreleasable pool in the platelet aggregates after com-enough to support the reaction together with the other
secretagogues. plete aggregation. Homogenization of the aggregates
liberates almost all 14C-5-HT into the soluble fraction,However, exogenously added ADP elicits a com-
pletely reversible aggregation in platelet-rich plasma while only a small but significant amount remains in the
insoluble fraction (Figure 4I). Similar pools of “unreleas-(Figure 4B), meeting our finding that ADP does not in-
duce -granule release from washed platelets (Figure able” 5-HT have been reported previously (Shirakawa
et al., 2000), although without explanations for this phe-2B). Although it has been reported previously that the
response to ADP is not accompanied by granule secre- nomenon. Interestingly, the retained 5-HT can be roughly
estimated to reach very high cytoplasmic concentra-tion (Maayani et al., 2001a, 2001b; Mohammad et al.,
1975) the underlying mechanism is still unknown. How- tions, of up to 500 to 600 M.
ever, even isolation procedures for native platelets have
been developed based on these findings (Mohammad 5-HT-Transamidation of Small GTPases
The secretion of - and dense granules has been dis-et al., 1975). Conversely, apyrase added in excess to
break down all secreted ADP leads to a delayed platelet sected showing that -granule release is regulated by
Rab4 (Shirakawa et al., 2000) and that extensive cy-aggregation without a preceding shape change after
collagen stimulation, and the requirement for 5-HT of toskeletal rearrangement occurs during shape change
and aggregation via RhoA signaling (Nishioka et al.,the remaining reaction is now discernable in Tph1/
platelets as compared to wild-type platelets (Figure 4C). 2001; Bodie et al., 2001).
Prompted by our findings that high [5-HT]i and [Ca2]iHowever, since Tph1/ platelets contain only about
5% of the wild-type 5-HT, the small difference in this are a prerequisite for secretion and aggregation, we
formed our hypothesis that platelet TGs could be mech-response suggests a 5-HT-mediated signaling mecha-
nism that is largely potentiated by downstream ef- anistically involved, since 5-HT is a substrate and Ca2
an activating signal for many of these enzymes (Dale etfectors. Prompted by these findings, we designed a
pharmacological approach to prove whether a cytosolic al., 2002). Streptolysin O-permeabilized wild-type plate-
lets lose over 80% of their cytosol and can be inducedrise in the 5-HT concentration ([5-HT]i) is involved in
-granule secretion (Figure 4D). Albeit contradictory to to secrete about 40% of their -granular contents upon
Ca2 addition when reconstituted with brain cytosol (Fig-the G protein hypothesis, Fen Flx-pretreated platelets
Serotonylation of Small GTPases
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ure 5A), as has been reported previously (Shirakawa et
al., 2000). Interestingly, brain cytosol (BC) is very rich in
TGs (Maggio et al., 2001; Tucholski et al., 2001; Citron
et al., 2000). In contrast, skeletal muscle cytosol (SMC),
which in comparison to BC is poor in TGs (Lee et al.,
2000), does not support -granule secretion even after
addition of exogenous 5-HT (Figure 5A). Moreover, ex-
ogenously added TG together with SMC leads to an
extensive secretion of -granular contents (Figure 5A),
revealing the indispensable need for TG in the release
reaction, which cannot be potentiated by further addi-
tion of 5-HT (Figure 5A). This lack of potentiation may
be explained by the fact that dense body 5-HT is rapidly
secreted from permeabilized platelets upon Ca2 addi-
tion (Shirakawa et al., 2000), reaching effective concen-
trations by itself.
Secretion from permeabilized Tph1/ platelets re-
constituted with BC and SMC resembles the wild-type
reactions (Figure 5B), and again, 5-HT addition without
TG does not lead to any -granule release. Only the
combination of SMC with 5-HT and TG leads to the vWf
secretion (Figure 5B). Moreover, the addition of TG to
Tph1/ platelets reconstituted with SMC does not lead
to increased exocytosis (Figure 5B), reflecting the lack
of 5-HT, and demonstrating the need for the enzyme
and 5-HT as the substrate for activation and secretion.
The sequences of known small GTPase substrates for
bacterial TGs RhoA, Rac1, and Cdc42 allow delineating
a TG substrate consensus within the GTP hydrolyzing
domain that can be found also in Rab GTPases (Figure
5C), suggesting that Rab4 and other Rab GTPases might
be suitable substrates as well. Tph1/ platelets pre-
loaded with 14C-5-HT and aggregated using Fen, Flx,
and -ms present many 14C-5-HT labeled bands in SDS-
PAGE as expected, especially in the high molecular
range (data not shown). This is not surprising, since
5-HT is transamidated to several high-molecular pro-
teins, such as vWf and fibrinogen (Dale et al., 2002).
However, also some bands in the range of 20–25 kDa
appear, and immunoprecipitation of RhoA and Ras iso-
forms reveal that RhoA, but not Ras isoforms, were co-
valently labeled with 14C-5-HT (Figure 5D). However, la-
beled Rab4 could not be detected by this method due
to low signal/noise ratio, but native Rab4 isolated from
skeletal muscle by immunoprecipitation serves as a sub-
strate for TG in vitro, incorporating 14C-5-HT (Figure 5E).
Tph1/ thrombocytes provide an excellent possibility
to offer other substrates to TG, avoiding competition
with the endogenous substrate 5-HT. Addition of various
concentrations of the alternative fluorescent TG sub-
strate monodansylcadaverine (MDC) together with the
enzyme and SMC mimics the action of 5-HT, although
Figure 3. Tph1/ Mice Are Less Prone to Succumb from Thrombo-
embolism and Thrombosis
(A) Fluorescent thrombus formation is detectable by intravital mi-
croscopy soon after FeCl3 injury of endothelial cells in Tph1/ ani-
mals, whereas platelet deposition is blunted in Tph1/ mice. The
few thrombi formed in Tph1/ usually detach spontaneously from
injured arterioles.
(B) Intravenous application of 200 g/ml collagen together with 10
M epinephrine is well tolerated by Tph1/ mice, whereas most of
the treated Tph1/ mice succumb in less than 15 min.
Cell
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Figure 4. G Protein Hypothesis Contradictory Platelet Aggregation
(A) After a short lag phase, collagen (20 g/ml) induces a pronounced shape change during which 5-HT and ADP become secreted, then
culminating in the aggregation response (compare with Figure 1C). The initial shape change is thought to depend on secreted ADP.
(B) Without collagen, ADP alone (20 M) elicits a completely reversible aggregation response without granule secretion in presence of plasma
protein, demonstrating that agglutination and aggregation cannot be distinguished using in vitro experiments.
(C) In presence of an excess of apyrase that immediately breaks down all secreted ADP, collagen stimulation (20 g/ml) still leads to an
irreversible although less efficient aggregation response without a preceding shape change. This response is supported by 5-HT as can be
appreciated by a delayed time (t 50 s) and magnitude (agg 10%) of the 5-HT deficient Tph1/ platelets. All plots are representative for
at least four independent experiments.
(D) Besides 5-HT, platelets contain three serotonergic components: the 5-HT2A receptor (5-HT2AR), the plasma membrane serotonin reuptake
transporter (SERT), and the vesicular monoamine transporter 2 (VMAT2). Intact platelets take up 5-HT by the SERT and store the monoamine
in vesicles by the VMAT2 (black arrows). Fenfluramine (Fen) is SERT-dependently transported into the cytoplasm and reverses the VMAT2
transport, increasing the cytoplasmic 5-HT concentration [5-HT]i to levels that reverse the SERT activity, resulting in a continuous slow release
of 5-HT (green arrows). After Fen, fluoxetine (Flx) addition completely blocks SERT, thereby trapping 5-HT in the platelet cytoplasm accelerating
the increase of [5-HT]i (red arrows). Flx before Fen blocks the entry of Fen into the platelets, thereby avoiding Fen-induced VMAT2 reversal
and increased [5-HT]i (dashed red lines). 5-HT2AR-specific agonists increase free calcium [Ca2]i via Gq (blue arrows). According to the G
protein hypothesis, neither Fen, Flx, or 5-HT2AR-dependent signaling nor combinations of these compounds should elicit any aggregation re-
sponses.
(E) Fen (1 M) followed by Flx (1M) does not elicit any platelet responses without concomitant 5-HT2AR stimulation. Addition of the 5-HT2AR
agonist -methyl-serotonin (-ms; 1.8 M) rapidly leads to extensive aggregation. Tph1/ platelets containing only about 5% of wild-type
5-HT levels exhibit a delayed response. Moreover, while omission of Flx has no influence on the response of wild-type platelets, Tph1/
platelets allow to resolve the [5-HT]i-dependent response. Obviously, a critical [5-HT]i must be reached for the aggregation response.
(F) As in (E), even 180 nM -ms leads to complete aggregation after Fen  Flx or Fen alone and again, only the Tph1/ response is resolved
in a [5-HT]i-dependent manner.
(G) 5-HT2AR stimulation with -ms (1.8 M) induces an almost not detectable agglutination (data not shown: no response with 180 nM -ms).
Addition of Fen (1M) leads to a complete aggregation response, which is delayed for more than 10 min in Tph1/ platelets compared with
wild-type platelets.
(H) Blockade of SERT with Flx (1 M) prior to Fen (1 M) avoids Fen entry into the cytoplasm and its action on VMAT2. The dependence of
the aggregation response on increased [5-HT]i is obvious from the insensitivity of the platelets to 180 nM -ms, a concentration that after
Fen  Flx regimen induces extensive spontaneous aggregation. Only an excessive addition of -ms (2 M) competing for SERT binding is
able to induce a response, although delayed for more than 5 min in wild-type and for more than 15 min in Tph1/ platelets. All plots are
representative for at least four independent experiments.
(I) After aggregation of Tph1/ platelets preloaded with 14C-5-HT, about 40 to 50% of the 14C-5-HT remain in the aggregates collected by
centrifugation and washing 3  with Tyrode-HEPES buffer (100%  3  washed resting platelets). Supernatants of sonicated aggregates
also contain about 40 to 50% of 14C-5-HT, while a 3 washed insoluble fraction retains about 5 to 8% of 14C-5-HT (results of one representative
experiment are shown; the sum of supernatant homogenate and debris homogenate is not significantly different from the not released value).
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Figure 5. Serotonylation of Small GTPases in Platelets
(A) Permeabilized wild-type platelets incubated at 37C while shaking with 1000 rpm after buffer addition do not release more vWf than resting
permeabilized platelets (column 1). In presence of 3 mg/ml brain cytosol (BC) protein, about 40% of the -granular contents become released
(column 2). Skeletal muscle cytosol (SMC) protein (3 mg/ml) does not induce significant -granule release (column 3), even if 5-HT (15 M)
is added (column 4). Addition of 25 mU guinea pig liver TG lead to about 60% release of vWf in presence and absence of 15 M added
5-HT (columns 5 and 6).
(B) The same treatment of permeabilized Tph1/ platelets as in (A) shows similar reactions for all conditions (columns 1 to 5), excepting for
omission of 5-HT (column 6). No significant release can be detected from permeabilized Tph1/ platelets in presence of SMC (3 mg/ml) and
TG (25 mU) in absence of exogenous 5-HT (column 6).
(C) Alignment of a selection of Ras-related small GTPases. The glutamine residue of the catalytic site (red), which has been shown to be
modified by bacterial TGs (light green) with concomitant constitutive activation, is conserved in most of the other shown GTPases (dark green),
excepting Rap1A (not colored).
(D) Aggregated wild-type platelets as described in Figure 4I were washed and sonicated in presence of a protease inhibitor cocktail followed
by immunoprecipitation with anti-Ras (all isoforms) and anti-RhoA. Only in the RhoA precipitate emerges a 14C-5-HT labeled signal of 24 kDa.
(E) Rab4-rich skeletal muscle cytosol was used for native immunoprecipitation of Rab4, and then treated with 25 mU TG and 14C-5-HT in
duplicate (1 and 2). Mock immunoprecipitations served as negative control (3 and 4).
to a lower extent (Figure 6A). Similar to 14C-5-HT, MDC is Discussion
transamidated to many high-molecular weight proteins
upon platelet stimulation, but also to proteins of about Primary hemostasis is a complex self-preserving reac-
24 kDa, presumably the small GTPases (Figure 6B), tion preventing major blood loss upon injury. The active
therefore demonstrating that this synthetic monoamine half-life of almost all platelet agonists is extremely short.
can functionally replace the endogenous substrate Inhibitors or enzymatic breakdown rapidly inactivate
5-HT. thrombin, thromboxanes, adrenalin, and adenine nucle-
Transamidation reactions with GST- and 6 His- otides. In contrast, secreted 5-HT is scavenged by active
tagged GTPases with MDC and guinea pig liver TG re- transport into platelets, thereby leading to a transiently
veal that Rab GTPases are excellent substrates (Figure elevated cytoplasmic concentration of this monoamine.
6C), while RhoA, one of the accepted substrates for We have recently shown that Gq stimulation drastically
bacterial TGs, is less efficiently transamidated by the reduces VMAT2-dependent vesicular uptake (Ho¨ltje et
mammalian enzyme (Figure 6D). However, 6 His-RhoA al., 2003), probably resulting in accumulation of cyto-
plasmic 5-HT to levels higher than previously expected.transamidated in vitro with either MDC or 5-HT reveals
that the modification leads to strong effector binding of The functional importance of this increase in [5-HT]i for
platelet aggregation was not appreciated previously.the GTPase even in the GDP bound form in rhotekin
pull-down assays (Figure 6F). It is not surprising that Tph1/ mice lacking 5-HT in
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Figure 6. Synthetic Monoamines Can Functionally Replace Endogenous Substrates for Constitutive Small GTPase Activation
(A) Permeabilized Tph1/ platelets were treated under the conditions described in Figure 5B (columns 1 to 3). Again, skeletal muscle cytosol
and TG without addition of a monoamine exhibits no release reaction [column 4; 6 in Figure 5B]. However, the addition of the synthetic
monoamine monodansylcadaverine (MDC) under the conditions of column 4 in Figure 5B leads to the release of -granular contents at various
concentrations (500 M and 1 mM; columns 5 and 6, respectively).
(B) Resting and aggregated Tph1/ platelet samples without MDC are completely fluorescence inactive (lanes 1 and 3). Resting Tph1/
platelets incubated with MDC exhibit two unknown labeled bands of about 43 and 110 kDa (lane 2), while MDC incubated platelets exhibit
many labeled proteins after aggregation, including bands at about 24 kDa (lane 4).
(C–E) In vitro transamidation of tagged GTPases with MDC reveal dose-dependent monoaminylation of GST-Rab4, GST-Rab27 (C), 6 His-
RhoA, and GST-RhoA (D) but no transamidation of GST alone (E; with bovine serum albumin as positive control). Shown are the UV-fluorescence
(upper images) and the Coomassie stainings of the same polyacrylamide gels (lower images).
(F) Rhotekin pull-down of reaction products as shown in (D), preincubated with nucleotides at the indicated concentrations, and anti-RhoA
detection of the active GTPase by immunoblotting. 100 nM GTP (about 50 molar excess) is hydrolyzed by Gln63 RhoA (lane 1, image 1) but
not by RhoA-MDC nor RhoA-5-HT (lane 1, images 2 and 3). GDP at inactivating 1 mM surprisingly leads to strong effector binding of RhoA-
MDC and RhoA-5-HT but not of Gln63 RhoA (lane 2, images 1–3). In negative controls without nucleotides, only slight background or no
effector binding occurs (lane 3, images 1–3). Image 4 shows equal loading control of the RhoA binding GST-fusion of rhotekin.
platelets exhibit a significant prolongation of experimen- gregatory compounds (Figure 1C). We confirmed our
hypothesis, that other mediators such as vWf and othertal bleeding times (Figure 1A), and that this phenotype
can be rescued by 5-HT application (Figure 1B). But constituents of platelet -granules, are responsible for
the impaired primary hemostasis in vivo. In vitro we haveit was surprising that Tph1/ platelets did not fail to
aggregate in vitro upon stimulation with several proag- demonstrated that 5-HT triggers the release of vWf, a
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representative protein of -granules, from platelets and
that ADP as the second agonist in dense core vesicles
only potentiates the 5-HT-induced release reaction (Fig-
ure 2B). Moreover, the prolonged bleeding time in
Tph1/ mice was rescued by infusion of commercial
preparations of vWf (Figure 2A).
Interestingly, injection of higher doses of vWf did not
completely normalize the prolonged bleeding time of
Tph1/ mice, indicating that the remaining prolonged
bleeding time was either due to the absence of 5-HT or
due to the difference in the multimeric forms of vWf
found in plasma and platelets. Although the latter expla-
nation is supported by the finding that patients with von
Willebrand disease type IIA who lack the larger multimeric
forms but have normal vWf concentrations in the circula-
tion show a prolonged bleeding time (Siess, 1989), but
this explanation is contradictory to the fact that infusion
of high doses of commercial plasma-derived vWf can Figure 7. Machinery of 5-HT-Induced Exocytosis of -Granules
be used to cure von Willebrand disease patients. from Platelets during Irreversible Aggregation
Therefore, other explanations are more probable: Upon stimulation of platelets by 5-HT, the phosphatidyl inositol
5-HT is known to constrict endothelium-denuded arter- pathway is activated, resulting in a rise of cytoplasmic Ca2. 5-HT
signaling is mediated by the Gq protein-coupled 5-HT2AR, andies, an important mechanism for the closure of vessels
moreover, by transport into the cytoplasm by SERT. Calcium acti-at sites of tissue injury (Cohen et al., 1983). Moreover,
vates TG, which uses 5-HT to transamidate small GTPases, suchvWf is not the only protein in -granules important for
as cytoplasmic RhoA and -granule-associated Rab4, therebyhemostasis and blood coagulation, and we only have
blocking the GTP-hydrolyzing activity of these proteins. Moreover,
chosen vWf as a representative marker of -granular calcium in complex with calmodulin (CaM) activates guanine nucleo-
release due to its easy detection by ELISA. In Tph1/ tide exchange factors (GEF), which aid the exchange of GDP for
mice, the release of fibrinogen, vitronectin, fibronectin, GTP on RhoA and Rab4. The lack of GTP hydrolysis renders the
serotonylated small GTPases constitutively active. RhoA and Rab4the prothrombin activating factor V, and several mem-
in their GTP bound conformation interact downstream with effectorbrane bound glycoproteins identified as collagen- and
molecules, resulting in cytoskeleton rearrangement and exocytosisvWf-receptors exteriorized after platelet activation
of -granules. The contents of -granules are released into the
(Siess, 1989) should be decreased. In addition, 5-HT is circulation (for example vWf, black circles) or exposed at the plasma
not only responsible for the release of proteins from membrane (for example glycoprotein IIb/IIIa and P-selectin), thereby
-granules as indicated by our data, but also for their supporting irreversible aggregation.
efficient binding to the platelet surface. It has recently
been shown, that 5-HT is covalently bound by a TG-
sis (Walther et al., 2003). Since thrombosis in coronary
catalyzed process to vWf, fibrinogen, factor V, and other
or cerebral arteries is the major cause of morbidity and
-granular proteins after secretion and then binds to
mortality worldwide, further understanding of the spe-
thrombospondin and fibrinogen on the surface of highly
cific hormonal role of 5-HT in hemostasis and thrombo-activated platelets (Dale et al., 2002; Szasz and Dale,
sis is important to possibly prevent and treat deleterious2002). Therefore, the substrate for this TG-dependent
hemorrhagic and cardiovascular disorders.binding enhancement is deeply decreased in Tph1/
Likely to be of greater importance is our finding thatplatelets, and the absence of all mentioned effects in
elevated cytoplasmic 5-HT concentrations are a crucialTph1/ mice may explain why exogenously added vWf
component of small GTPase activation in rapid exocy-cannot completely rescue the prolonged bleeding time
totic processes from platelets (Figures 4 and 5) andof these animals (Figure 2A). Concordant with this multi-
possibly also in other vesicular trafficking processes.factorial view, vWf knockout mice exhibit a reduced,
Furthermore, we could show that this activation occursalbeit persistent experimental thrombus formation
through a rapid covalent TG-mediated binding of 5-HT(Denis et al., 1998), since all other -granular proteins
to at least the small GTPases Rab4 and RhoA (Figurescan be released by 5-HT in this model. The phenotype
5 and 6), suggesting a potential receptor independentof our 5-HT-deficient mice (Figure 3) resembles more
mechanism of 5-HT signaling in the periphery (Figurethat of fibrinogen/vWf double-knockout mice, in which
7). This mechanism assigns a central role to TGs duringthrombus instability and detachment has been demon-
physiologic processes that depend on active mono-strated (Ni et al., 2000).
amine transport into target cells.Our data show that Tph1/ animals are less prone
Thus, our data provide evidence for a receptor-inde-to succumb from vessel occlusion in thromboembolism
pendent signaling pathway for 5-HT that we named “sero-and thrombosis due to the described thrombus instabil-
tonylation,” which leads to -granule exocytosis fromity (Figure 3). From a clinical point of view, this beneficial
platelets. Since TGs also accept other biogenic mono-effect renders a therapeutic 5-HT reduction useful, even
amines, such as histamine and catecholamines as sub-taking into account the observed prolonged bleeding
strates, and even synthetic monoamines, such as MDCas a side effect of 5-HT-absence. These findings might
(Figure 6), it can be expected that histaminylation andopen new avenues to ameliorate vascular disease and
catecholaminylation could be involved in analogous sig-its complications in thrombotic diseases by specific inhi-
bition of TPH1 thereby impeding peripheral 5-HT synthe- naling mechanisms, and therefore “monoaminylation”
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should be the most suitable term for all of these pro- aminylation of small GTPases remain. For instance, it
cesses. Interestingly, monoaminylation leads to active will be important to learn how cells handle constitutively
GTPases even in the GDP bound form, uncoupling nu- active GTPases to avoid constant signaling through their
cleotide binding and hydrolysis from their activity in sig- downstream effectors (Doye et al., 2002). Now that we
naling (Figure 6F). It will be of major importance to eluci- recognize the importance of the TG/monoamine-depen-
date not only the stability of the monoaminylated dent activation of small GTPases, it is a matter of time
GTPases in the GTP- and GDP bound forms but also before we explore the full extent of the biological impli-
the dissociation rates of the nucleotides in follow-up cations of this finding.
studies.
Experimental ProceduresOur data helps to understand numerous pathophysio-
logical effects, such as the surprising mitogenic effect of
General Materials and Methods5-HT in hyperplasia of pulmonary artery smooth muscle
All chemicals were purchased from Sigma (Deisenhofen, Germany)
cells (PA-SMCs) in primary pulmonary hypertension or obtained from the otherwise indicated companies. Tph1/ and
(PHH), which has been shown to depend exclusively on wild-type animals were bred as described (Walther et al., 2003).
SERT activity and cytosolic 5-HT accumulation (Edda- Antibodies were obtained from Sigma and Santa Cruz Biotechnol-
ogy (CA 95060, USA). GST-GTPase fusions were cloned and purifiedhibi et al., 2001). Mitogenesis of PA-SMCs induced by
using standard procedures. RhoA cDNA was kindly provided by5-HT appears to occur by way of signaling through a
F. Hofmann (Hannover, Germany). TG reactions with MDC weremitogen-activated protein kinase (MAPK)-dependent
performed as previously described (Case and Stein, 2003) using
pathway and phosphorylation of extracellular signal- guinea pig liver TG (Sigma). The rhotekin binding kit for the pull-
regulated kinases 1 and 2 (ERK1/2; Eddahibi et al., 2002). down of active RhoA was used according to the manufacturer’s
Interestingly, it has been recently established that reti- instructions (Pierce, Germany).
noic acid-mediated TG overexpression leads to cyto-
Determination of Bleeding Timesskeletal rearrangement and activation of MAPK and
Bleeding times were determined basically as previously describedERK1/2 in a RhoA-dependent pathway, in which RhoA is
(Holland, 1976). Briefly, test animals were anaesthetized with keta-activated by transamidation with radioactive putrescine,
mine and the terminal 2 mm portion of the tail was severed using
without elucidation of the endogenous amino donor a razor blade. Bleeding time was measured by a stopwatch to the
(Singh et al., 2003). Collectively these data suggest that nearest second using a filter paper intermittently applied to the
constitutive activation of RhoA by transamidation with adherent drop of blood, without touching the wound.
5-HT and consecutive downstream signaling via MAPK
Determination of Hematological Parametersand ERK1/2 may be responsible for the observed hyper-
and Plasma vWf and FVIIIplasia of PA-SMCs in PPH. Furthermore, high cytosolic
vWf was determined in citrated plasma using an enzyme immunoas-5-HT concentrations are likely to be the crucial event
say (Diagnostic International, vWf Antigen ELISA Kit, Schriesheim,
leading to the mitogenic response, by analogy to the Germany) according to the manufacturers’ indications. The mean
high cytosolic 5-HT concentration that we have eluci- value of control animals was arbitrarily considered as 100% and
dated to be essential in platelet aggregation (Figures 5 used as reference.
Standard hematological parameters and plasma factor VIII levelsand 6). Thus, serotonylation of small GTPases rather
were determined double-blinded by technical staff of the Franz-than the controversially discussed effect of superoxide
Volhard-Clinic in Berlin-Buch, using a Coulter counter and a STAanions resulting from 5-HT internalization (Eddahibi et
Factor VIII kit (Boehringer Mannheim, Germany), respectively.al., 2002) might be responsible for the observed patho-
physiological effect of enhanced SERT-mediated 5-HT
Platelet Aggregation and Secretion Studies
transport. Blood (9 vol.) was collected from the vena cava inferior in 300
It is difficult to predict which other signaling events units/ml Heparin (1 vol.). After addition of half a volume of Tyrode-
might depend on monoaminylation and which of the HEPES buffer (TH: 134 mM NaCl, 0.34 mM Na2HPO4, 2.9 mM KCl,
12 mM NaHCO3, 20 mM HEPES, 5 mM glucose, 1 mM MgCl2; [pHmore than 60 known small GTPases might become acti-
7.3]), the samples were centrifuged 7.5 min at room temperature andvated by transamidation. This is further complicated by
200 g. Platelets were then sedimented by a 5 min centrifugation atthe fact that eight mammalian TGs have been identified
room temperature and 1000  g. Platelet pellets were resuspendedto date (Griffin et al., 2002) and that little is known about in TH at a density of 3  108 platelets/ml. After recalcification of
their tissue-specific expression and substrate prefer- 220 l portions with 5 l 50 mM CaCl2 in siliconized glass cuvettes,
ence. However, it is likely that specific mammalian TGs aggregation reactions were started by addition of proaggregatory
preferentially act in restricted signaling mechanisms compounds in 25 l TH to the indicated final concentrations, and
the time-courses of the transmission-increments were recorded inthat are still to be elucidated. Further support for this
a platelet aggregation profiler (Mo¨lab, Germany).hypothesis comes from the observation that bacterial
For analysis of vWf secretion, the platelets were centrifuged andTGs display preference for different GTPases (Aktories
resuspended two times more with TH to wash away plasma vWf
et al., 2000; Masuda et al., 2000; Doye et al., 2002). It and fibrinogen. Final density was adjusted to 6  108 platelets/ml,
has been established that TGs and 5-HT both act in and aggregation was performed as described above, using physio-
signaling that leads either to differentiation or apoptosis logically effective concentrations of the proaggregatory substances
(Singh et al., 2001, 2003; Azmitia, 2001). Interestingly, it ADP (14 M), 5-HT (12 M), and collagen (30 g/ml). Ten min after
addition of the proaggregatory substances, the aggregates werehas recently been reported that 5-HT induces apoptosis
centrifuged, and vWf concentrations in the supernatants were deter-in biopsy-like Burkitt lymphoma cells, an effect that can
mined using the ELISA kit, as described above.be completely reversed by SSRIs (Serafeim et al., 2002).
Permeabilization of platelets with streptolysin-O and secretion
Based on our data it is tempting to speculate that this from (6–7)  107 permeabilized platelets was done basically as de-
apoptotic effect might be mediated by TG-dependent scribed (Ho¨ltje et al., 2003 and Shirakawa et al., 2000, respectively).
serotonylation of small GTPases. Of course, many intri- Supernatants of resting and sonicated resting platelets were used
as 0% and 100% reference, respectively.guing questions about the control of TG-dependent mono-
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Thromboembolism Test Flatau, G., Gagnoux, L., Piechaczyk, M., Boquet, P., and Lemichez,
E. (2002). CNF1 exploits the ubiquitin-proteasome machinery to re-In mice anaesthetized with sodium pentobarbital (80 mg/kg), a colla-
gen/epinephrine mixture (5 ml/kg of a saline-based solution con- strict Rho GTPase activation for bacterial host cell invasion. Cell
111, 553–564.taining 200 g/ml collagen and 10 M adrenaline) was injected into
the tail vein. Survival was monitored up to 1 hr after injection as Eddahibi, S., Humbert, M., Fadel, E., Raffestin, B., Darmon, M.,
reported (Offermanns et al., 1997). Capron, F., Simonneau, G., Dartevelle, P., Hamon, M., and Adnot,
S. (2001). Serotonin transporter overexpression is responsible for
In Vivo Thrombosis Model pulmonary artery smooth muscle hyperplasia in primary pulmonary
Mice were anaesthetized with sodium pentobarbital (80 mg/kg) for hypertension. J. Clin. Invest. 108, 1141–1150.
intravital microscopy of mesenteric microvessels in vivo, as de-
Eddahibi, S., Raffestin, B., Hamon, M., and Adnot, S. (2002). Is the
scribed for the rat (Katayama et al., 2000), using the nonfluorescent
serotonin transporter involved in the pathogenesis of pulmonary
fluorochrome-precursor carboxyfluorescein diacetate succinimidyl
hypertension? J. Lab. Clin. Med. 139, 194–201.
ester, which is converted to carboxyfluorescein succinimidyl ester
Greenberg, C.S., Birckbichler, P.J., and Rice, R.H. (1991). Transglu-specifically in platelets. Induction of vascular injury and thrombus
taminases: multifunctional cross-linking enzymes that stabilize tis-formation with FeCl3 (30l of a 250 mM solution; Sigma) and intravital
sues. FASEB J. 5, 3071–3077.microscopy were performed as described (Denis et al., 1998).
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